NICE Guidance on Mounjaro: What It Means If You're Already Prescribed It

NICE guidance on weight management injections, including Mounjaro, sets out the conditions under which tirzepatide may be recommended as part of a specialist weight management programme. In general terms, the guidance considers factors such as body mass index (BMI) thresholds and the presence of at least one weight-related health condition, though the precise criteria are reviewed and updated over time.

Key points from the guidance

• Tirzepatide is prescription-only: Mounjaro can only be used where it has been prescribed by a qualified healthcare professional following an assessment of individual suitability.
• It is intended alongside lifestyle support: The guidance positions Mounjaro as part of a broader programme that includes dietary and physical activity support — not as a standalone intervention.
• Prescriber-led dose management: Decisions about starting dose, titration, and duration of treatment are made by the prescriber based on individual response and tolerability. No guidance document — and certainly no app — replaces that clinical relationship.
• The guidance evolves: NICE reviews its technology appraisals periodically. The most up-to-date version of the guidance is always the definitive reference; your prescriber or the NICE website is the best place to check current recommendations.

For a broader look at how Mounjaro works and what to expect on treatment, the Mounjaro overview covers the essentials. You may also find it useful to read about the specific NICE guidelines for Mounjaro in more detail.

It is worth noting that guidance frameworks like NICE's apply within particular healthcare systems. If you are prescribed Mounjaro outside the UK, your own national health authority will have its own assessment process — the principles around clinical criteria and prescriber oversight are broadly similar, but the specific rules differ by country.

Having a prescription is the start, not the finish. Consistency — taking each weekly dose as scheduled, logging how you feel, and keeping a clear record of your progress — is what turns a prescription into results over time. That is where a tracking companion becomes genuinely useful.

GLP Trackr's dose logging feature lets you record every injection: the date, the dose strength, and the site. Because Mounjaro is a once-weekly injection with a titration schedule guided by your prescriber, having an accurate log means you always know exactly where you are in your treatment — and you have something concrete to discuss at your next appointment.

Alongside dose tracking, the daily check-in captures how you're feeling day to day — energy, mood, appetite, and sleep — so you build a picture of your journey beyond just the number on the scale. If your prescriber ever asks how you've been getting on between appointments, your GLP Trackr log gives you a clear, organised answer rather than a best guess.

Mounjaro is also associated with commonly reported side effects such as nausea, digestive changes, and fatigue, particularly in the early weeks or after a dose increase. Logging these in the app's side-effect tracker helps you spot patterns and share meaningful information with your healthcare professional. If any symptoms feel severe, persistent, or worrying, contact your prescriber or doctor promptly — the app supports that conversation but is not a substitute for it.

For more on what Mounjaro involves day to day, the full Mounjaro guide is a good place to start. If you have questions about the medication itself — including anything that isn't a tablet — it is worth being clear that Mounjaro does not come in tablet form; it is an injectable pen.

Ready to keep your journey organised? Download GLP Trackr on the App Store or Google Play — your first 7 days are completely free.